MYC and B-cell non-Hodgkin lymphoma: To determine if picolog inhibited growth of additional murine and human MYC-induced lymphoma cells, 100 nM picolog was administered to a panel of additional T- and B-cell lymphomas of human and murine origin (including human Jurkat T-cell lymphoma, CA-46 B-cell lymphoma, and 6780 murine T-cell lymphoma, Figure 2).